Furthermore, an EF B cell response has been associated with severe COVID-19 and predicts poor clinical outcomes, and severe COVID-19 cases have been characterized by poor GC formation in secondary lymphoid organs (Chen et al., 2020; Kaneko et al., 2020; Woodruff et al., 2020). This evidence concerns the gene ALYREF and COVID-19.